{"id":"https://openalex.org/W2887166320","doi":"https://doi.org/10.1158/1538-7445.am2018-4093","title":"Abstract 4093: Preclinical evaluation of novel treatment strategies in patient-derived xenograft (PDX) models of pancreatic cancer","display_name":"Abstract 4093: Preclinical evaluation of novel treatment strategies in patient-derived xenograft (PDX) models of pancreatic cancer","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2887166320","doi":"https://doi.org/10.1158/1538-7445.am2018-4093","mag":"2887166320"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-4093","doi":"https://doi.org/10.1158/1538-7445.am2018-4093","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-4093","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039652183","display_name":"Diana Behrens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana Behrens","raw_affiliation_strings":["1EPO GMBH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1EPO GMBH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063023898","display_name":"Britta B\u00fcttner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Britta B\u00fcttner","raw_affiliation_strings":["1EPO GMBH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1EPO GMBH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045331477","display_name":"Rita  Teresa Lawlor","orcid":"https://orcid.org/0000-0003-3160-0634","observed_orcids":["https://orcid.org/0000-0003-3160-0634"]},"institutions":[{"id":"https://openalex.org/I119439378","display_name":"University of Verona","ror":"https://ror.org/039bp8j42","country_code":"IT","type":"education","lineage":["https://openalex.org/I119439378"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rita L. Lawlor","raw_affiliation_strings":["2ARC-NET University of Verona, Verona, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2ARC-NET University of Verona, Verona, Italy;","institution_ids":["https://openalex.org/I119439378"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058816620","display_name":"Christopher Heeschen","orcid":"https://orcid.org/0000-0002-1158-8554","observed_orcids":["https://orcid.org/0000-0002-1158-8554"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Christopher Heeschen","raw_affiliation_strings":["3QMUL, Barts Cancer Institute, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3QMUL, Barts Cancer Institute, London, United Kingdom;","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045880069","display_name":"Malte Buchholz","orcid":"https://orcid.org/0000-0002-2833-995X","observed_orcids":["https://orcid.org/0000-0002-2833-995X"]},"institutions":[{"id":"https://openalex.org/I161103922","display_name":"Philipps University of Marburg","ror":"https://ror.org/01rdrb571","country_code":"DE","type":"education","lineage":["https://openalex.org/I161103922"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Malte Buchholz","raw_affiliation_strings":["4Philipps University Marburg, Marburg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Philipps University Marburg, Marburg, Germany;","institution_ids":["https://openalex.org/I161103922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071888326","display_name":"Jens Thomas Siveke","orcid":"https://orcid.org/0000-0002-8772-4778","observed_orcids":["https://orcid.org/0000-0002-8772-4778"]},"institutions":[{"id":"https://openalex.org/I4210119759","display_name":"Essen University Hospital","ror":"https://ror.org/02na8dn90","country_code":"DE","type":"funder","lineage":["https://openalex.org/I4210119759"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jens Siveke","raw_affiliation_strings":["5DKFZ, University Hospital Essen, Essen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5DKFZ, University Hospital Essen, Essen, Germany;","institution_ids":["https://openalex.org/I4210119759"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064749364","display_name":"Antje Margret Wengner","orcid":"https://orcid.org/0009-0009-5772-1945","observed_orcids":["https://orcid.org/0009-0009-5772-1945"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Antje M. Wengner","raw_affiliation_strings":["6Bayer AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Bayer AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108136094","display_name":"Ashok Kumar Saluja","orcid":"https://orcid.org/0000-0002-1139-9083","observed_orcids":["https://orcid.org/0000-0002-1139-9083"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashok Saluja","raw_affiliation_strings":["7University of Miami, Miami, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7University of Miami, Miami, FL","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002682008","display_name":"Jens Hoffmann","orcid":"https://orcid.org/0000-0003-3880-1658","observed_orcids":["https://orcid.org/0000-0003-3880-1658"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jens Hoffmann","raw_affiliation_strings":["1EPO GMBH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1EPO GMBH, Berlin, Germany;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"4093","last_page":"4093"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9319999814033508},{"id":"https://openalex.org/keywords/minnelide","display_name":"Minnelide","score":0.9020000100135803},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.9670000076293945},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9829999804496765},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.8999999761581421},{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.625},{"id":"https://openalex.org/keywords/cancer-stem-cells","display_name":"cancer stem cells","score":0.652999997138977},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6520000100135803},{"id":"https://openalex.org/keywords/drug-response","display_name":"drug response","score":0.40299999713897705},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.6259999871253967}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.8562191724777222},{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.8353227376937866},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7806563377380371},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.7125354409217834},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5402836799621582},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5314333438873291},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5191739797592163},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5145056247711182},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4184996485710144},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40113213658332825},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3983854055404663},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32190680503845215},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11610263586044312},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.0},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1538-7445.am2018-4093","doi":"https://doi.org/10.1158/1538-7445.am2018-4093","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-4093","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmh:oai:bibliographie.ub.uni-due.de:ubo_mods_00149751","doi":null,"is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-4093","pdf_url":null,"source":{"id":"https://openalex.org/S7407055102","display_name":"Universit\u00e4tsbibliographie, Universit\u00e4t Duisburg-Essen","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"poster_abstract"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.49000000953674316}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1970498696","https://openalex.org/W2126322332","https://openalex.org/W4205828341","https://openalex.org/W3031675857","https://openalex.org/W2596055884","https://openalex.org/W2885862304","https://openalex.org/W3031244932","https://openalex.org/W4281720666","https://openalex.org/W1965851372","https://openalex.org/W2038866393"],"abstract_inverted_index":{"Abstract":[0],"Pancreatic":[1],"cancer":[2,87,304,389],"(PC)":[3],"remains":[4],"a":[5,30,324],"lethal":[6],"disease":[7],"with":[8,124,134,167,192,206,230],"only":[9,287],"3":[10],"-":[11],"8%":[12],"of":[13,20,33,47,178,197,212,223,233,243,264,278,289,302,312,378,387,393],"patients":[14],"surviving":[15],"5":[16,262],"years":[17],"after":[18,112,175,220],"diagnosis":[19],"the":[21,26,44,56,60,67,93,135,221,231,279,283,290,327,337,394],"tumor":[22,209,218,271],"(WHO,":[23],"2012).":[24],"Within":[25,51],"EU":[27],"project":[28],"\u201cCAM-PaC\u201d":[29],"comprehensive":[31],"panel":[32,297],"thirty":[34],"patient-derived":[35,383],"PC":[36,352],"xenografts":[37],"(PDX)":[38,385],"was":[39,160,171,185,225],"established":[40],"and":[41,66,73,84,107,117,123,155,164,183,194,235,261,310,314],"used":[42],"for":[43,75,351,397],"efficacy":[45,205,285],"screening":[46],"new":[48],"therapeutic":[49],"options.":[50],"this":[52],"study,":[53],"responders":[54,253],"to":[55,238,248,259,266,306,340],"MPS-1":[57,157],"inhibitor":[58,69,158],"BAY1161909,":[59],"Super":[61],"Enhancer":[62],"disrupting":[63],"agent":[64],"Minnelide":[65,169,260,269],"MEK":[68],"Trametinib":[70,184,281],"were":[71,80,90,101,115,149,250],"identified":[72,133,251],"analyzed":[74],"potential":[76],"biomarkers.":[77],"Patient":[78],"tumors":[79],"collected":[81],"during":[82],"surgery":[83],"circulating":[85],"tumorigenic":[86],"stem":[88],"cells":[89],"isolated":[91],"from":[92],"peripheral":[94],"blood":[95],"using":[96,151],"VAR2CSA-coated":[97],"magnetic":[98],"beads.":[99],"Both":[100],"transplanted":[102],"subcutaneously":[103],"into":[104],"NOD/SCID/IL2y-":[105],"mice":[106,111,228],"propagated":[108],"in":[109,162,165,227,276,286,382],"NMRI:nu/nu":[110],"engraftment.":[113],"These":[114],"morphologically":[116],"molecularly":[118],"characterized":[119],"by":[120,140],"histopathological":[121,193],"revision":[122],"NGS":[125],"panels,":[126],"designed":[127],"based":[128],"on":[129],"pathway":[130],"aggregated":[131],"genes":[132],"International":[136],"Cancer":[137,398,411],"consortium":[138],"(described":[139],"Bailey":[141],"et":[142],"al.,":[143],"Nature":[144],"531,":[145],"2016).":[146],"Standard":[147],"drugs":[148,329],"applied":[150,172],"clinically":[152],"relevant":[153],"dosages":[154],"schedule.":[156],"BAY1161909":[159,200,234],"given":[161],"monotherapy":[163,201],"combination":[166,232],"Abraxane.":[168],"(MTD)":[170],"second":[173],"line":[174],"three":[176],"cycles":[177],"chemotherapy":[179,224],"(Cisplatin,":[180],"Abraxane,":[181],"Gemcitabine)":[182],"tested":[186,247,291,328],"as":[187,252,318,320],"monotherapy.":[188],"All":[189],"PDX":[190,245,292,296],"correlated":[191],"molecular":[195,338],"characteristics":[196],"patient":[198],"tumours.":[199],"showed":[202],"moderate":[203],"anti-tumor":[204],"an":[207],"average":[208],"growth":[210,255,272,309],"inhibition":[211,256,273],"30%":[213],"(p":[214],">":[215,257],"0.05).":[216],"However,":[217],"relapse":[219],"end":[222],"delayed":[226],"treated":[229],"Abraxane":[236,239],"compared":[237],"alone.":[240],"13":[241],"out":[242,263],"22":[244],"models":[246,386],"date":[249],"(tumor":[254],"50%)":[258],"11":[265],"Trametinib.":[267],"While":[268],"induced":[270,330],"above":[274],"80%":[275],"32%":[277],"models,":[280],"achieved":[282],"same":[284],"9%":[288],"models.":[293],"The":[294],"described":[295],"clearly":[298],"reflects":[299],"clinical":[300],"situation":[301],"pancreatic":[303,388],"due":[305],"their":[307],"histologic":[308],"detection":[311],"inherent":[313],"acquired":[315],"treatment":[316,349,380],"resistance":[317],"well":[319],"recurrent":[321],"disease.":[322],"In":[323],"few":[325],"cases,":[326],"complete":[331],"remissions.":[332],"We":[333],"are":[334],"currently":[335],"analyzing":[336],"data":[339],"determine":[341],"response":[342],"markers.":[343],"Our":[344],"approach":[345],"may":[346],"offer":[347],"personalized":[348],"options":[350],"patients.":[353],"Citation":[354],"Format:":[355],"Diana":[356],"Behrens,":[357],"Britta":[358],"B\u00fcttner,":[359],"Rita":[360],"L.":[361],"Lawlor,":[362],"Christopher":[363],"Heeschen,":[364],"Malte":[365],"Buchholz,":[366],"Jens":[367,374],"Siveke,":[368],"Antje":[369],"M.":[370],"Wengner,":[371],"Ashok":[372],"Saluja,":[373],"Hoffmann.":[375],"Preclinical":[376],"evaluation":[377],"novel":[379],"strategies":[381],"xenograft":[384],"[abstract].":[390],"In:":[391],"Proceedings":[392],"American":[395],"Association":[396],"Research":[399],"Annual":[400],"Meeting":[401],"2018;":[402],"2018":[403],"Apr":[404],"14-18;":[405],"Chicago,":[406],"IL.":[407],"Philadelphia":[408],"(PA):":[409],"AACR;":[410],"Res":[412],"2018;78(13":[413],"Suppl):Abstract":[414],"nr":[415],"4093.":[416]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-10T00:00:00"}